Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
Dividends/Share Growth Under PressureDecelerating
Percentile Rank18
Year-over-Year Change
Year-over-year dividends per share growth
Latest
0.00%
↓ 100% vs avg
Percentile
P18
Within normal range
Average
37.29%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | -100.00% |
| Q1 2019 | 132.09% |
| Q4 2018 | 1697.97% |
| Q3 2018 | 0.00% |
| Q2 2018 | -100.00% |
| Q1 2018 | -85.53% |
| Q4 2017 | -19.15% |
| Q3 2017 | -54.19% |
| Q2 2017 | -0.24% |
| Q1 2017 | 0.15% |
| Q4 2016 | -2.36% |
| Q3 2016 | 0.56% |
| Q2 2016 | 2.34% |
| Q1 2016 | 20.04% |